risperidone has been researched along with Enuresis in 6 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Enuresis: Involuntary discharge of URINE after expected age of completed development of urinary control. This can happen during the daytime (DIURNAL ENURESIS) while one is awake or during sleep (NOCTURNAL ENURESIS). Enuresis can be in children or in adults (as persistent primary enuresis and secondary adult-onset enuresis).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Risperidone has demonstrated efficacy for acute (8 week) and intermediate length (6 month) management of severe irritability and aggression in children and adolescents with autism." | 9.20 | Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial. ( Aman, M; Arnold, LE; Ghuman, J; Grados, M; Hellings, J; Hollway, JA; McCracken, J; McDougle, CJ; Nagaraja, HN; Posey, DJ; Rettiganti, M; Scahill, L; Shah, B; Swiezy, NB; Tierney, E; Vitiello, B, 2015) |
| "Data about their use in the treatment of enuresis also exist." | 5.32 | Reversible nocturnal enuresis in children receiving SSRI with or without risperidone: presentation of five cases. ( Aksu, HB; Kandil, ST; Ozyavuz, R, 2004) |
| "Risperidone has demonstrated efficacy for acute (8 week) and intermediate length (6 month) management of severe irritability and aggression in children and adolescents with autism." | 5.20 | Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial. ( Aman, M; Arnold, LE; Ghuman, J; Grados, M; Hellings, J; Hollway, JA; McCracken, J; McDougle, CJ; Nagaraja, HN; Posey, DJ; Rettiganti, M; Scahill, L; Shah, B; Swiezy, NB; Tierney, E; Vitiello, B, 2015) |
| "Data about their use in the treatment of enuresis also exist." | 1.32 | Reversible nocturnal enuresis in children receiving SSRI with or without risperidone: presentation of five cases. ( Aksu, HB; Kandil, ST; Ozyavuz, R, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aman, M | 1 |
| Rettiganti, M | 1 |
| Nagaraja, HN | 1 |
| Hollway, JA | 1 |
| McCracken, J | 1 |
| McDougle, CJ | 1 |
| Tierney, E | 1 |
| Scahill, L | 1 |
| Arnold, LE | 1 |
| Hellings, J | 1 |
| Posey, DJ | 1 |
| Swiezy, NB | 1 |
| Ghuman, J | 1 |
| Grados, M | 1 |
| Shah, B | 1 |
| Vitiello, B | 1 |
| Kandil, ST | 1 |
| Aksu, HB | 1 |
| Ozyavuz, R | 1 |
| Kantrowitz, JT | 1 |
| Srihari, VH | 1 |
| Tek, C | 1 |
| Bennett, JA | 1 |
| Keck, PE | 1 |
| Wallhausser, LJ | 1 |
| Took, KJ | 1 |
| Buck, BJ | 1 |
| Poyurovsky, M | 1 |
| Weizman, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Emotion Awareness and Skills Enhancement (EASE) Program: A Clinical Trial[NCT03432832] | 113 participants (Actual) | Interventional | 2018-01-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for risperidone and Enuresis
| Article | Year |
|---|---|
Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.
Topics: Adolescent; Aggression; Antipsychotic Agents; Autistic Disorder; Child; Child, Preschool; Double-Bli | 2015 |
Desmopressin for risperidone-induced enuresis.
Topics: Administration, Intranasal; Adult; Antipsychotic Agents; Deamino Arginine Vasopressin; Double-Blind | 1994 |
4 other studies available for risperidone and Enuresis
| Article | Year |
|---|---|
Reversible nocturnal enuresis in children receiving SSRI with or without risperidone: presentation of five cases.
Topics: Adolescent; Antipsychotic Agents; Child; Drug Therapy; Drug Therapy, Combination; Enuresis; Female; | 2004 |
Three cases of risperidone-induced enuresis.
Topics: Aripiprazole; Enuresis; Female; Humans; Middle Aged; Piperazines; Quinolones; Risperidone; Schizophr | 2006 |
Enuresis with combined risperidone and SSRI use.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; | 1996 |
Risperidone-induced nocturnal enuresis.
Topics: Adult; Antipsychotic Agents; Enuresis; Humans; Male; Risperidone | 1997 |